Zhang Xuefei, Ren Xiaoqing, Zhang Qi, Li Zheyi, Ma Shuaipeng, Bao Jintao, Li Zeyang, Bai Xue, Zheng Liangjun, Zhang Zhong, Shang Shujiang, Zhang Chen, Wang Chuangui, Cao Liu, Wang Qingsong, Ji Jianguo
1 State Key Laboratory of Protein and Plant Gene Research, College of Life Sciences, Peking University , Beijing, China .
2 State Key Laboratory of Biomembrane and Membrane Biotechnology, Peking University , Beijing, China .
Antioxid Redox Signal. 2016 Feb 20;24(6):312-28. doi: 10.1089/ars.2015.6403. Epub 2015 Nov 19.
Parkinson's disease (PD) heavily affects humans and little is known about its cause and pathogenesis. Sirtuin 3 (Sirt3) plays a key role in regulating mitochondrial dysfunction, which is the main cause of DAergic neuronal loss in PD. We investigated the mechanisms of neuroprotective role of Sirt3 in DAergic neuronal survival.
Sirt3 was reduced in 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP)-treated neurons with its overexpression being neuroprotective. We identified that Sirt3 interacted with manganese superoxide dismutase (SOD2) and adenosine triphosphate (ATP) synthase β and modulated their activities by deacetylating SOD2 (K130) and ATP synthase β (K485) to prevent reactive oxygen species accumulation and ATP depletion, and to alleviate DAergic neuronal death upon MPTP treatment. Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) interacted with estrogen-related receptor alpha (ERRα) that bound to the Sirt3 promoter as its transcription factor to regulate Sirt3 expression and DAergic neuronal death. In the mouse midbrain, MPTP administration led to the loss of PGC-1α and Sirt3, high acetylation level of SOD2 and ATP synthase β, and the specific loss of DAergic neurons, while Sirt3 overexpression could protect against DAergic neuronal loss. Sirt3 knockout mice exhibited more sensitive and more DAergic neuronal loss to MPTP treatment.
The study provides new insights into a critical PGC-1α/ERRα-Sirt3 pathway, linking regulation of mitochondrial protein acetylation and DAergic neuronal death in PD pathogenesis, which provide a potential therapeutic strategy and target in PD treatment.
These results provide a vital PGC-1α/ERRα-Sirt3 pathway that protects against DAergic neuronal death by directly deacetylating SOD2 (K130) and ATP synthase β (K485) in PD.
帕金森病(PD)对人类影响严重,但其病因和发病机制仍知之甚少。沉默调节蛋白3(Sirt3)在调节线粒体功能障碍中起关键作用,而线粒体功能障碍是PD中多巴胺能神经元丧失的主要原因。我们研究了Sirt3在多巴胺能神经元存活中的神经保护作用机制。
在1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)处理的神经元中,Sirt3表达降低,而过表达具有神经保护作用。我们发现Sirt3与锰超氧化物歧化酶(SOD2)和三磷酸腺苷(ATP)合酶β相互作用,并通过使SOD2(K130)和ATP合酶β(K485)去乙酰化来调节它们的活性,以防止活性氧积累和ATP耗竭,并减轻MPTP处理后多巴胺能神经元的死亡。过氧化物酶体增殖物激活受体γ共激活因子1α(PGC-1α)与雌激素相关受体α(ERRα)相互作用,ERRα作为转录因子与Sirt3启动子结合,调节Sirt3表达和多巴胺能神经元死亡。在小鼠中脑,MPTP给药导致PGC-1α和Sirt3丧失、SOD2和ATP合酶β的高乙酰化水平以及多巴胺能神经元的特异性丧失,而Sirt3过表达可防止多巴胺能神经元丧失。Sirt3基因敲除小鼠对MPTP处理表现出更敏感且多巴胺能神经元丧失更多。
该研究为关键的PGC-1α/ERRα-Sirt3通路提供了新见解,该通路将线粒体蛋白乙酰化调节与PD发病机制中的多巴胺能神经元死亡联系起来,为PD治疗提供了潜在的治疗策略和靶点。
这些结果提供了一条重要的PGC-1α/ERRα-Sirt3通路,该通路通过直接使PD中的SOD2(K130)和ATP合酶β(K485)去乙酰化来保护多巴胺能神经元免于死亡。